6th Annual Stanford Drug Discovery Symposium (SDDS 2022)

STANFORD, Calif., April 21, 2022 (Newswire.com) - Organized by the Stanford Cardiovascular Institute, along with its partners, the 6th Annual Stanford Drug Discovery Symposium is a free, virtual symposium that will be held Monday-Tuesday, April 25-26, 2022. This is an exciting opportunity to hear about drug discovery from leaders in the field. Speakers include leaders at major pharmaceutical companies, federal policymakers, venture capitalist investors, IP lawyers, and scientists making groundbreaking advances. For more information, visit https://tinyurl.com/SDDS2022.

Register for free at https://bit.ly/3vzXGEC.

This symposium provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs and improving patient care. We look forward to an exciting two days of talks and discussion. Our Lifetime Achievement Award will be given to Katalin Karikó, Ph.D., Senior VP, BioNTech, whose research was pivotal in the creation of the mRNA COVID-19 vaccines. 

https://tinyurl.com/SDDS2022

Register: https://bit.ly/3vzXGEC

Thank you also to all our SDDS2022 sponsors: Abbvie, Alfred Mann Institute, Alwaysraise LLC, Amgen, Arctoris, Astellas, Biocom, California Life Sciences Alliance, Cancer Institute, CIRM, Cooley, Cytokinetics, Gilead, Greenstone Biosciences, Keystone, Merck, Novartis, Servier, Stanford Health Care, Thermo Fisher Scientific, Vala, Walden Catalyst, Wilson Sonsini.

Source: Stanford Cardiovascular Institute